Blockade of the Tumor Necrosis Factor-Related Apoptosis Inducing Ligand Death Receptor DR5 Prevents β-Amyloid Neurotoxicity

[1]  M. Naoi,et al.  Overexpression of amyloid precursor protein induces susceptibility to oxidative stress in human neuroblastoma SH-SY5Y cells , 2006, Journal of Neural Transmission.

[2]  M. Coletta,et al.  Aβ(31–35) peptide induce apoptosis in PC 12 cells: Contrast with Aβ(25–35) peptide and examination of underlying mechanisms , 2005, Neurochemistry International.

[3]  G. Dawson,et al.  Novel aspects of accumulation dynamics and Aβ composition in transgenic models of AD , 2004, Neurobiology of Aging.

[4]  R. Reiter,et al.  Kinetics of the neuroinflammation-oxidative stress correlation in rat brain following the injection of fibrillar amyloid-β onto the hippocampus in vivo , 2004, Journal of Neuroimmunology.

[5]  M. Memo,et al.  TRAIL is expressed in the brain cells of Alzheimer's disease patients , 2004, Neuroreport.

[6]  Jialin Zheng,et al.  TNF-related apoptosis-inducing ligand mediates human neuronal apoptosis: links to HIV-1-associated dementia , 2004, Journal of Neuroimmunology.

[7]  T. Pozzan,et al.  The presenilin 2 M239I mutation associated with familial Alzheimer's disease reduces Ca2+ release from intracellular stores , 2004, Neurobiology of Disease.

[8]  F. Heppner,et al.  Current Concepts and Future Prospects for Alzheimer Disease Vaccines , 2004, Alzheimer disease and associated disorders.

[9]  P. Secchiero,et al.  Tumour necrosis factor‐related apoptosis‐inducing ligand sequentially activates pro‐survival and pro‐apoptotic pathways in SK‐N‐MC neuronal cells , 2003, Journal of neurochemistry.

[10]  M. Tabaton,et al.  Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis. , 2003, Free radical biology & medicine.

[11]  Mamoru Ito,et al.  Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Q. Peng,et al.  Pycnogenol® protects neurons from amyloid-β peptide-induced apoptosis , 2002 .

[13]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[14]  I. Bechmann,et al.  Lack of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand But Presence of Its Receptors in the Human Brain , 2002, The Journal of Neuroscience.

[15]  W Pieter Medendorp,et al.  Rotational Remapping in Human Spatial Memory during Eye and Head Motion , 2002, The Journal of Neuroscience.

[16]  Z. Wang,et al.  Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity , 2001, Nature Medicine.

[17]  C. Culmsee,et al.  A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid β‐peptide , 2001 .

[18]  M. Memo,et al.  Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path? , 2001, Trends in Neurosciences.

[19]  X. Wu,et al.  Peg3/Pw1 promotes p53-mediated apoptosis by inducing Bax translocation from cytosol to mitochondria. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  I. Bechmann,et al.  Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL) , 2000, The Lancet.

[21]  H. Vanderstichele,et al.  Aging Increased Amyloid Peptide and Caused Amyloid Plaques in Brain of Old APP/V717I Transgenic Mice by a Different Mechanism than Mutant Presenilin1 , 2000, The Journal of Neuroscience.

[22]  S. Aizawa,et al.  Role of p53 in DNA strand break‐induced apoptosis in organotypic slice culture from the mouse cerebellum , 2000, Journal of neuroscience research.

[23]  T. Shea,et al.  Beta-amyloid-induced calcium influx induces apoptosis in culture by oxidative stress rather than tau phosphorylation. , 2000, Brain research. Molecular brain research.

[24]  D. Moechars,et al.  Premature death in transgenic mice that overexpress a mutant amyloid precursor protein is preceded by severe neurodegeneration and apoptosis , 1999, Neuroscience.

[25]  E. Alnemri,et al.  Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor. , 1999, Cancer research.

[26]  I. Herr,et al.  CD95 Ligand (Fas-L/APO-1L) and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Mediate Ischemia-Induced Apoptosis in Neurons , 1999, The Journal of Neuroscience.

[27]  Mark D. Johnson,et al.  Evidence for involvement of Bax and p53, but not caspases, in radiation‐induced cell death of cultured postnatal hippocampal neurons , 1998, Journal of neuroscience research.

[28]  D. Green.  Apoptotic Pathways The Roads to Ruin , 1998, Cell.

[29]  Xiaodong Wang,et al.  Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors , 1998, Cell.

[30]  Bruce A. Yankner,et al.  Aging renders the brain vulnerable to amyloid β-protein neurotoxicity , 1998, Nature Medicine.

[31]  John C. Lee,et al.  Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL* , 1998, The Journal of Biological Chemistry.

[32]  M. Memo,et al.  Induction of tumour‐suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurones triggered by excitatory amino acids , 1998, The European journal of neuroscience.

[33]  C. Smith,et al.  The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. , 1997, Immunity.

[34]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[35]  Henning Walczak,et al.  TRAIL‐R2: a novel apoptosis‐mediating receptor for TRAIL , 1997, The EMBO journal.

[36]  R. Gentz,et al.  An antagonist decoy receptor and a death domain-containing receptor for TRAIL. , 1997, Science.

[37]  W I Wood,et al.  Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. , 1997, Science.

[38]  V. Rotter,et al.  Involvement of p53 in cell differentiation and development. , 1997, Biochimica et biophysica acta.

[39]  M. Baudry,et al.  Induction of Tumor Suppressor p53 and DNA Fragmentation in Organotypic Hippocampal Cultures Following Excitotoxin Treatment , 1997, Experimental Neurology.

[40]  Arul M. Chinnaiyan,et al.  The Receptor for the Cytotoxic Ligand TRAIL , 1997, Science.

[41]  R. Neve,et al.  Age-Dependent Neuronal and Synaptic Degeneration in Mice Transgenic for the C Terminus of the Amyloid Precursor Protein , 1996, The Journal of Neuroscience.

[42]  D. Selkoe,et al.  Amyloid β-Protein and the Genetics of Alzheimer's Disease* , 1996, The Journal of Biological Chemistry.

[43]  S. Marsters,et al.  Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family* , 1996, The Journal of Biological Chemistry.

[44]  M. Peter,et al.  Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor. , 1995, The EMBO journal.

[45]  C. Gray,et al.  Neurodegeneration mediated by glutamate and β-amyloid peptide: a comparison and possible interaction , 1995, Brain Research.

[46]  R. Crumrine,et al.  Attenuation of p53 Expression Protects against Focal Ischemic Damage in Transgenic Mice , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[47]  C. Cotman,et al.  Rapid Communication: Ca2+ Channel Blockers Attenuate β‐Amyloid Peptide Toxicity to Cortical Neurons in Culture , 1994 .

[48]  Carl W. Cotman,et al.  Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[49]  T. Lion,et al.  Parental origin of chromosomes involved in the translocation t(9;22) , 1992, Nature.

[50]  D. Selkoe,et al.  Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.

[51]  D. Selkoe,et al.  Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.

[52]  C. Cotman,et al.  β-Amyloid neurotoxicity: A discussion of in vitro findings , 1992, Neurobiology of Aging.

[53]  D. Selkoe,et al.  Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. , 1992, The Journal of biological chemistry.

[54]  M. Mattson,et al.  beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[55]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[56]  L. Villa-komaroff,et al.  Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. , 1989, Science.

[57]  M. Coletta,et al.  Abeta(31-35) peptide induce apoptosis in PC 12 cells: contrast with Abeta(25-35) peptide and examination of underlying mechanisms. , 2005, Neurochemistry international.

[58]  H. Levine.  The Amyloid Hypothesis and the clearance and degradation of Alzheimer's beta-peptide. , 2004, Journal of Alzheimer's disease : JAD.

[59]  M. Memo,et al.  Neutralization of TRAIL death pathway protects human neuronal cell line from β-amyloid toxicity , 2003, Cell Death and Differentiation.

[60]  A. Kowalska.  Amyloid precursor protein gene mutations responsible for early-onset autosomal dominant Alzheimer's disease. , 2003, Folia neuropathologica.

[61]  Q. Peng,et al.  Pycnogenol protects neurons from amyloid-beta peptide-induced apoptosis. , 2002, Brain research. Molecular brain research.

[62]  C. Geula,et al.  Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. , 1998, Nature medicine.

[63]  I. Krantz,et al.  KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor gene , 1997, Nature Genetics.

[64]  C. Cotman,et al.  Ca2+ channel blockers attenuate beta-amyloid peptide toxicity to cortical neurons in culture. , 1994, Journal of neurochemistry.

[65]  D. Teplow,et al.  Amyloid beta-peptide is produced by cultured cells during normal metabolism. , 1992, Nature.

[66]  Thomas Wisniewski,et al.  Magnetic Resonance in Medicine 51:794–798 (2004) MRI Assessment of Neuropathology in a Transgenic Mouse Model of Alzheimer’s Disease , 2022 .